Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
04/2006
04/13/2006US20060079486 Lipopolymer conjugates
04/13/2006US20060079484 Antithrombotic effect
04/13/2006US20060079431 Adducts of thiols with glycidyl ethers; to reduce surface tension in water-based systems; foaming performance; coatings, inks, adhesives, fountain solutions for lithographic printing, cleaning formulation, metalworking fluids, agricultural formulations, electronics cleaning and semiconductor, detergents
04/13/2006DE19637425B4 Neue N-Vinyllactam-Derivate und deren Polymere New N-vinyl lactam derivatives and their polymers
04/13/2006DE112004000910T5 Verfahren zur Herstellung eines Phosphonitrilsäureesters A method for producing a Phosphonitrilsäureesters
04/13/2006DE102004049614A1 New phosphinate complex useful as flame protective agent for polyester, polyamide and epoxide resin and their manufactured products
04/13/2006CA2582908A1 Macrocyclic sh2 domain binding inhibitors
04/13/2006CA2582752A1 Fluorophosphonocinnamic compounds, synthesis and uses for treating disorders caused by oxidative stress
04/13/2006CA2582658A1 Method for producing thioether compound
04/13/2006CA2581913A1 Chelating agents for heavy metal removal
04/12/2006EP1645553A1 Process for the preparation of cyclic ketones
04/12/2006EP1644430A1 Method for producing phosphonate-modified silicones
04/12/2006EP1644389A1 Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
04/12/2006EP1644388A2 Bisphosphonate complexes
04/12/2006EP1644383A2 Novel organosilicon compounds and a method for their production
04/12/2006EP1644363A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
04/12/2006EP1644325A2 Methods and compositions for treating amyloid-related diseases
04/12/2006EP1644314A1 Method for producing difluoro-acetyl-acetic acid alkylesters
04/12/2006EP1644025A1 Water-soluble shps as novel alkylating agents
04/12/2006EP1644012A1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments
04/12/2006EP1644001A2 Pancratistatin cyclic phosphate prodrugs an phenpanstatin cyclic phosphate prodrugs
04/12/2006EP1643987A2 Podophyllotoxin derivatives
04/12/2006EP1643961A2 Cox-2 and faah inhibitors
04/12/2006EP1560602B1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof
04/12/2006EP1039897B1 Inadone and tetralone compounds for inhibiting cell proliferation
04/12/2006CN1757622A 2-hydroxy-3-alkoxypropyl sulfides, sulfones, and sulfoxides: new surface active agents
04/12/2006CN1250520C Use of compositions consisting of cations compounds and proton donors
04/11/2006US7026509 Cyclic phosphazene compounds and use thereof as additives of perfluoropolyether oils
04/11/2006US7026498 Coordination catalyst containing ligand
04/11/2006US7026495 Using beta-substituted styrenes instead of terminal olefin compounds such as unsubstituted styrenes to react with a ruthenium complex;recovered and reused; oxidation resistance; storage stability; efficiency; polymerization; cuprous chloride-free and nontoxic; materials handling
04/11/2006US7026482 Process for preparing imidazoquinolinamines
04/11/2006US7026469 Compositions and methods of double-targeting virus infections and cancer cells
04/11/2006US7026288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
04/11/2006US7026017 Organometallic monoacylalkylphosphines
04/11/2006US7025904 Metal free, heat resistance vinyl chloride polymers comprising mixtures of ionomers and sulfur compounds as stabilizer agents
04/11/2006CA2262910C 3-heteroatom substituted cyclopentadienyl-containing metal complexes and olefin polymerization process
04/11/2006CA2233842C Novel heterocyclic derivatives having indoline, indole or tetrahydroquinoline ring and pharmaceutical use thereof
04/06/2006WO2006036743A2 Halocombstatins and methods of synthesis thereof
04/06/2006WO2006036732A2 Process for releasing and extracting phosphatides from a phosphatide-containing matrix
04/06/2006WO2006034784A1 Heptazine derivatives containing phosphorus, method for the production thereof and use thereof as flame retardants
04/06/2006WO2006026747A3 Diphenylethylene compounds and uses thereof
04/06/2006WO2005118601A3 Sulfonylethyl phosphorodiamidates for use in the treatment of cancer
04/06/2006WO2005061501A3 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
04/06/2006US20060074157 Dialkylphosphinic salts
04/06/2006US20060074074 Reacting compounds such as 5-(3,4-dimethoxybenzoyl)-2-(1-isopropoxycarbonyloxy-2-methylpropyl)-2-1,2,3-triazole-4-carboxylate with carbonyl compounds, reacting with an alcohol to produce 1-(1-Isopropoxycarbonyloxyethyl)-7,8-dimethoxy-4(5H),10-dioxo-1H-1,2,3-triazolo[4,5-c][1]benzazepine
04/06/2006US20060074072 2-[3-(4-chlorophenyl)ureido] N-[4-(2-oxo-2H-pyridin-1-yl)phenyl]-4-methanesulfonylbutyramide; prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors
04/06/2006US20060074054 Phospho-indoles as HIV inhibitors
04/06/2006US20060073992 synergistic mixtures of a diisodecyl pentaerythritol diphosphite, and nonylated diphenylamines (tradename Naugalube 438L) that impart excellent oxidation resistance and are particularly suitable for use in a high temperature iron-catalyzed (extreme) environment
04/06/2006US20060073358 Cyclometalated transition metal complex and organic electroluminescent device using the same
04/06/2006DE102004047257A1 Phosphor-haltige Heptazinderivate, Verfahren zu deren Herstellung und deren Verwendung Phosphorus-containing heptazine derivatives, processes for their preparation and their use
04/06/2006DE102004045220A1 Neue Arzneimittel New drugs
04/06/2006CA2582046A1 Halocombstatins and methods of synthesis thereof
04/05/2006EP1642642A2 Synthesis of recyclable chiral metathesis catalysts
04/05/2006EP1642583A2 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
04/05/2006EP1641807A2 Aromatic compounds as aldolase inhibitors
04/05/2006EP1641468A2 Use of s1p
04/05/2006EP1467813B1 Stabilization of fluorophosphite-containing catalysts
04/05/2006EP1453777B1 Functionalized higher diamondoids
04/05/2006EP1435630B1 Proton conductor, process for its production and electrochemical devices
04/05/2006EP1409494B1 Stabilized derivatives of ascorbic acid -3- phosphate
04/05/2006EP1041976B1 Polyamide oligomers
04/05/2006EP0800397B1 Bone mass anabolic composition comprising olpadronate
04/05/2006CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
04/05/2006CN1249035C 4-imino-N-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators
04/05/2006CN1249022C Method for producing cyanovaleric acid or esters thereof
04/05/2006CN1249020C Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
04/05/2006CN1249006C Hydroformylation process utilizing multidentate phosphite ligands
04/04/2006US7022878 such as lithium tetrakis (trifluoroacetate) borate and/or lithium tetrakis (difluoroacetate) borate, having excellent solubility against a nonaqueous solvent; improved electroconductivity
04/04/2006US7022868 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof
04/04/2006US7022866 Phosphonites
04/04/2006US7022860 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10 -dioxo-2H-1,2,3-triazolo(4,5-c)(1)benzazepine, for example; chemical intermediates, synthesis using relatively inexpensive reagents
04/04/2006US7022833 Process for the preparation of phosphorothioate triesters
04/04/2006US7022786 Ligands, complexes and their use for the polymerization of olefins
04/04/2006US7022779 Vinyl carboxylates, epoxy-containing silyl compounds, ketimines and oxazolidines, and an epoxy resin
04/04/2006US7022726 ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
04/04/2006US7022725 Isoxazole derivatives
04/04/2006CA2235765C Azulenyl nitrone spin trapping agents, methods of making and using same
04/04/2006CA2231199C 1,2 chemiluminescent dioxetanes of improved performance
03/2006
03/30/2006WO2006034445A1 1,4-hydroquinone functionalized phosphynates and phosphonates
03/30/2006WO2006034266A2 Sulfonyl hydrazines as hypoxia-selective antineoplastic agents
03/30/2006WO2006032893A2 Trityl derivatives for enhancing mass spectrometry
03/30/2006WO2006032380A1 Quaternary alkaloid derivatives of chelidonium majus l
03/30/2006WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
03/30/2006WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
03/30/2006US20060069281 Catalyst prepared by reacting a phosphine with a diimine and optionally one or more equivalents of an acid halide, a sulfonyl halide, a phosphoryl halide, or an acid anhydride in the substantial absence of O2 to form the diazaphosphacycle; for asymmetric hydroformylation processes
03/30/2006US20060069278 Process for the preparation of alk(en)ylphosphoric ester salts
03/30/2006US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
03/30/2006US20060069247 Phosphitylation process
03/30/2006US20060069066 3-(4-(3-guanidinophenyl)-1,2,3-triazol-1-yl)benzyl phosphoric acid hydrochloride; obesity, non-insulin dependent diabetes mellitus, insulin-dependent condition, affective disorder, neurodegenerative diseases, psychotic disease; compounds having hydrophobic moiety to a terminus of a peptide GSK-3
03/30/2006US20060068988 Oxidation catalyst and process
03/30/2006US20060068041 Contacting with water or alcohol and sodium, magnesium or calcium sulfate to release phosphatides; separating the phosphatide enriched solvent portion from the phosphatide depleted matrix portion, and recovering the phosphatides from the phosphatide enriched solvent portion
03/30/2006DE102004046356A1 Verfahren zur Herstellung von Alk(en)ylphosphorsäureestersalzen A process for the production of alk (en) ylphosphorsäureestersalzen
03/30/2006CA2593202A1 Quaternary alkaloid derivatives of chelidonium majus l
03/30/2006CA2575269A1 Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents
03/29/2006EP1640475A2 Precursor compounds for deposition of ceramic and metal films and preparation methods thereof
03/29/2006EP1640411A1 Reactive flame retardants and flame-retarded resin products
03/29/2006EP1640376A1 Process for the preparation of salts of alk(en)ylphosphoric acid esters
03/29/2006EP1640067A2 Phosphazenium salt phase transfer catalysts
03/29/2006EP1638912A2 Process for the preparation of cinnamaldehyde compounds
03/29/2006EP1638565A2 Substituted piperidine compounds and methods of their use